866-997-4948(US-Canada Toll Free)

EMEA (Europe, Middle East and Africa) Celiac Disease Market Report 2017

Published By :

QYResearch

Published Date : Aug 2017

Category :

Pharmaceutical

No. of Pages : 113 Pages

In this report, the EMEA Celiac Disease market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Celiac Disease for these regions, from 2012 to 2022 (forecast)
Europe: Germany, France, UK, Russia, Italy and Benelux;
Middle East: Saudi Arabia, Israel, UAE and Iran;
Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Celiac Disease market competition by top manufacturers/players, with Celiac Disease sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
F. Hoffmann-La Roche
Johnson & Johnson
Merck
Pfizer
ADMA Biologics
Amgen
Anthera Pharmaceuticals
Bayer
Biogen
BioLineRx
Biotest
Bristol-Myers Squibb
Celgene
Takeda Pharmaceutical
Novartis
LFB Group
Kedrion Biopharma

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
Distension
Diarrhea
Anorexia
Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Celiac Disease for each application, including
First line of treatment
Second line of treatment

Table of Contents

EMEA (Europe, Middle East and Africa) Celiac Disease Market Report 2017
1 Celiac Disease Overview
1.1 Product Overview and Scope of Celiac Disease
1.2 Classification of Celiac Disease
1.2.1 EMEA Celiac Disease Market Size (Sales) Comparison by Type (2012-2022)
1.2.2 EMEA Celiac Disease Market Size (Sales) Market Share by Type (Product Category) in 2016
1.2.3 Distension
1.2.4 Diarrhea
1.2.5 Anorexia
1.2.6 Others
1.3 EMEA Celiac Disease Market by Application/End Users
1.3.1 EMEA Celiac Disease Sales (Volume) and Market Share Comparison by Application (2012-2022
1.3.2 First line of treatment
1.3.3 Second line of treatment
1.4 EMEA Celiac Disease Market by Region
1.4.1 EMEA Celiac Disease Market Size (Value) Comparison by Region (2012-2022)
1.4.2 Europe Status and Prospect (2012-2022)
1.4.3 Middle East Status and Prospect (2012-2022)
1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Celiac Disease (2012-2022)
1.5.1 EMEA Celiac Disease Sales and Growth Rate (2012-2022)
1.5.2 EMEA Celiac Disease Revenue and Growth Rate (2012-2022)

2 EMEA Celiac Disease Competition by Manufacturers/Players/Suppliers, Region, Type and Application
2.1 EMEA Celiac Disease Market Competition by Players/Manufacturers
2.1.1 EMEA Celiac Disease Sales Volume and Market Share of Major Players (2012-2017)
2.1.2 EMEA Celiac Disease Revenue and Share by Players (2012-2017)
2.1.3 EMEA Celiac Disease Sale Price by Players (2012-2017)
2.2 EMEA Celiac Disease (Volume and Value) by Type/Product Category
2.2.1 EMEA Celiac Disease Sales and Market Share by Type (2012-2017)
2.2.2 EMEA Celiac Disease Revenue and Market Share by Type (2012-2017)
2.2.3 EMEA Celiac Disease Sale Price by Type (2012-2017)
2.3 EMEA Celiac Disease (Volume) by Application
2.4 EMEA Celiac Disease (Volume and Value) by Region
2.4.1 EMEA Celiac Disease Sales and Market Share by Region (2012-2017)
2.4.2 EMEA Celiac Disease Revenue and Market Share by Region (2012-2017)
2.4.3 EMEA Celiac Disease Sales Price by Region (2012-2017)

3 Europe Celiac Disease (Volume, Value and Sales Price), by Players, Countries, Type and Application
3.1 Europe Celiac Disease Sales and Value (2012-2017)
3.1.1 Europe Celiac Disease Sales Volume and Growth Rate (2012-2017)
3.1.2 Europe Celiac Disease Revenue and Growth Rate (2012-2017)
3.2 Europe Celiac Disease Sales and Market Share by Type
3.3 Europe Celiac Disease Sales and Market Share by Application
3.4 Europe Celiac Disease Sales Volume and Value (Revenue) by Countries
3.4.1 Europe Celiac Disease Sales Volume by Countries (2012-2017)
3.4.2 Europe Celiac Disease Revenue by Countries (2012-2017)
3.4.3 Germany Celiac Disease Sales and Growth Rate (2012-2017)
3.4.4 France Celiac Disease Sales and Growth Rate (2012-2017)
3.4.5 UK Celiac Disease Sales and Growth Rate (2012-2017)
3.4.6 Russia Celiac Disease Sales and Growth Rate (2012-2017)
3.4.7 Italy Celiac Disease Sales and Growth Rate (2012-2017)
3.4.8 Benelux Celiac Disease Sales and Growth Rate (2012-2017)

4 Middle East Celiac Disease (Volume, Value and Sales Price), by Region, Type and Application
4.1 Middle East Celiac Disease Sales and Value (2012-2017)
4.1.1 Middle East Celiac Disease Sales Volume and Growth Rate (2012-2017)
4.1.2 Middle East Celiac Disease Revenue and Growth Rate (2012-2017)
4.2 Middle East Celiac Disease Sales and Market Share by Type
4.3 Middle East Celiac Disease Sales and Market Share by Application
4.4 Middle East Celiac Disease Sales Volume and Value (Revenue) by Countries
4.4.1 Middle East Celiac Disease Sales Volume by Countries (2012-2017)
4.4.2 Middle East Celiac Disease Revenue by Countries (2012-2017)
4.4.3 Saudi Arabia Celiac Disease Sales and Growth Rate (2012-2017)
4.4.4 Israel Celiac Disease Sales and Growth Rate (2012-2017)
4.4.5 UAE Celiac Disease Sales and Growth Rate (2012-2017)
4.4.6 Iran Celiac Disease Sales and Growth Rate (2012-2017)

5 Africa Celiac Disease (Volume, Value and Sales Price) by Players, Countries, Type and Application
5.1 Africa Celiac Disease Sales and Value (2012-2017)
5.1.1 Africa Celiac Disease Sales Volume and Growth Rate (2012-2017)
5.1.2 Africa Celiac Disease Revenue and Growth Rate (2012-2017)
5.2 Africa Celiac Disease Sales and Market Share by Type
5.3 Africa Celiac Disease Sales and Market Share by Application
5.4 Africa Celiac Disease Sales Volume and Value (Revenue) by Countries
5.4.1 Africa Celiac Disease Sales Volume by Countries (2012-2017)
5.4.2 Africa Celiac Disease Revenue by Countries (2012-2017)
5.4.3 South Africa Celiac Disease Sales and Growth Rate (2012-2017)
5.4.4 Nigeria Celiac Disease Sales and Growth Rate (2012-2017)
5.4.5 Egypt Celiac Disease Sales and Growth Rate (2012-2017)
5.4.6 Algeria Celiac Disease Sales and Growth Rate (2012-2017)

6 EMEA Celiac Disease Manufacturers/Players Profiles and Sales Data
6.1 F. Hoffmann-La Roche
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Celiac Disease Product Type, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 F. Hoffmann-La Roche Celiac Disease Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Johnson & Johnson
6.2.1 Company Basic Information, Manufacturing Base and Competitors
6.2.2 Celiac Disease Product Type, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Johnson & Johnson Celiac Disease Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Merck
6.3.1 Company Basic Information, Manufacturing Base and Competitors
6.3.2 Celiac Disease Product Type, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Merck Celiac Disease Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Pfizer
6.4.1 Company Basic Information, Manufacturing Base and Competitors
6.4.2 Celiac Disease Product Type, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Pfizer Celiac Disease Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 ADMA Biologics
6.5.1 Company Basic Information, Manufacturing Base and Competitors
6.5.2 Celiac Disease Product Type, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 ADMA Biologics Celiac Disease Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Amgen
6.6.1 Company Basic Information, Manufacturing Base and Competitors
6.6.2 Celiac Disease Product Type, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Amgen Celiac Disease Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Anthera Pharmaceuticals
6.7.1 Company Basic Information, Manufacturing Base and Competitors
6.7.2 Celiac Disease Product Type, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Anthera Pharmaceuticals Celiac Disease Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Bayer
6.8.1 Company Basic Information, Manufacturing Base and Competitors
6.8.2 Celiac Disease Product Type, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Bayer Celiac Disease Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 Biogen
6.9.1 Company Basic Information, Manufacturing Base and Competitors
6.9.2 Celiac Disease Product Type, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Biogen Celiac Disease Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 BioLineRx
6.10.1 Company Basic Information, Manufacturing Base and Competitors
6.10.2 Celiac Disease Product Type, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 BioLineRx Celiac Disease Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview
6.11 Biotest
6.12 Bristol-Myers Squibb
6.13 Celgene
6.14 Takeda Pharmaceutical
6.15 Novartis
6.16 LFB Group
6.17 Kedrion Biopharma

7 Celiac Disease Manufacturing Cost Analysis
7.1 Celiac Disease Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Celiac Disease

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Celiac Disease Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Celiac Disease Major Manufacturers in 2016
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA Celiac Disease Market Forecast (2017-2022)
11.1 EMEA Celiac Disease Sales, Revenue and Price Forecast (2017-2022)
11.1.1 EMEA Celiac Disease Sales and Growth Rate Forecast (2017-2022)
11.1.2 EMEA Celiac Disease Revenue and Growth Rate Forecast (2017-2022)
11.1.3 EMEA Celiac Disease Price and Trend Forecast (2017-2022)
11.2 EMEA Celiac Disease Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Celiac Disease Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Celiac Disease Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Celiac Disease Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Celiac Disease Sales Forecast by Type (2017-2022)
11.7 EMEA Celiac Disease Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer


List of Table

List of Tables and Figures

Figure Product Picture of Celiac Disease
Figure EMEA Celiac Disease Sales Volume (K Units) by Type (2012-2022)
Figure EMEA Celiac Disease Sales Volume Market Share by Type (Product Category) in 2016
Figure Distension Product Picture
Figure Diarrhea Product Picture
Figure Anorexia Product Picture
Figure Others Product Picture
Figure EMEA Celiac Disease Sales Volume (K Units) by Application (2012-2022)
Figure EMEA Sales Market Share of Celiac Disease by Application in 2016
Figure First line of treatment Examples
Figure Second line of treatment Examples
Figure EMEA Celiac Disease Market Size (Million USD) by Region (2012-2022)
Figure Europe Celiac Disease Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Celiac Disease Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Celiac Disease Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Celiac Disease Revenue (Million USD) Status and Forecast by Countries
Figure Africa Celiac Disease Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Celiac Disease Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Celiac Disease Sales Volume and Growth Rate (2012-2022)
Figure EMEA Celiac Disease Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Celiac Disease Market Major Players Product Sales Volume (K Units) (2012-2017)
Table EMEA Celiac Disease Sales Volume (K Units) of Major Players (2012-2017)
Table EMEA Celiac Disease Sales Share by Players (2012-2017)
Figure 2016 Celiac Disease Sales Share by Players
Figure 2017 Celiac Disease Sales Share by Players
Figure EMEA Celiac Disease Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Celiac Disease Revenue (Million USD) by Players (2012-2017)
Table EMEA Celiac Disease Revenue Share by Players (2012-2017)
Table 2016 EMEA Celiac Disease Revenue Share by Players
Table 2017 EMEA Celiac Disease Revenue Share by Players
Table EMEA Celiac Disease Sale Price (USD/Unit) by Players (2012-2017)
Table EMEA Celiac Disease Sales (K Units) and Market Share by Type (2012-2017)
Table EMEA Celiac Disease Sales Share by Type (2012-2017)
Figure Sales Market Share of Celiac Disease by Type (2012-2017)
Figure EMEA Celiac Disease Sales Market Share by Type (2012-2017)
Table EMEA Celiac Disease Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Celiac Disease Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Celiac Disease by Type in 2016
Table EMEA Celiac Disease Sale Price (USD/Unit) by Type (2012-2017)
Table EMEA Celiac Disease Sales (K Units) and Market Share by Application (2012-2017)
Table EMEA Celiac Disease Sales Share by Application (2012-2017)
Figure Sales Market Share of Celiac Disease by Application (2012-2017)
Figure EMEA Celiac Disease Sales Market Share by Application in 2016
Table EMEA Celiac Disease Sales (K Units) and Market Share by Region (2012-2017)
Table EMEA Celiac Disease Sales Share by Region (2012-2017)
Figure Sales Market Share of Celiac Disease by Region (2012-2017)
Figure EMEA Celiac Disease Sales Market Share in 2016
Table EMEA Celiac Disease Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Celiac Disease Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Celiac Disease by Region (2012-2017)
Figure EMEA Celiac Disease Revenue Market Share Regions in 2016
Table EMEA Celiac Disease Sales Price (USD/Unit) by Region (2012-2017)
Figure Europe Celiac Disease Sales (K Units) and Growth Rate (2012-2017)
Figure Europe Celiac Disease Revenue and Growth Rate (2012-2017)
Table Europe Celiac Disease Sales (K Units) by Type (2012-2017)
Table Europe Celiac Disease Market Share by Type (2012-2017)
Figure Europe Celiac Disease Market Share by Type in 2016
Table Europe Celiac Disease Sales (K Units) by Application (2012-2017)
Table Europe Celiac Disease Market Share by Application (2012-2017)
Figure Europe Celiac Disease Market Share by Application in 2016
Table Europe Celiac Disease Sales (K Units) by Countries (2012-2017)
Table Europe Celiac Disease Sales Market Share by Countries (2012-2017)
Figure Europe Celiac Disease Sales Market Share by Countries (2012-2017)
Figure Europe Celiac Disease Sales Market Share by Countries in 2016
Table Europe Celiac Disease Revenue (Million USD) by Countries (2012-2017)
Table Europe Celiac Disease Revenue Market Share by Countries (2012-2017)
Figure Europe Celiac Disease Revenue Market Share by Countries (2012-2017)
Figure Europe Celiac Disease Revenue Market Share by Countries in 2016
Figure Germany Celiac Disease Sales (K Units) and Growth Rate (2012-2017)
Figure France Celiac Disease Sales (K Units) and Growth Rate (2012-2017)
Figure UK Celiac Disease Sales (K Units) and Growth Rate (2012-2017)
Figure Russia Celiac Disease Sales (K Units) and Growth Rate (2012-2017)
Figure Italy Celiac Disease Sales (K Units) and Growth Rate (2012-2017)
Figure Benelux Celiac Disease Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Celiac Disease Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Celiac Disease Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Celiac Disease Sales (K Units) by Type (2012-2017)
Table Middle East Celiac Disease Market Share by Type (2012-2017)
Figure Middle East Celiac Disease Market Share by Type (2012-2017)
Table Middle East Celiac Disease Sales (K Units) by Applications (2012-2017)
Table Middle East Celiac Disease Market Share by Applications (2012-2017)
Figure Middle East Celiac Disease Sales Market Share by Application in 2016
Table Middle East Celiac Disease Sales Volume (K Units) by Countries (2012-2017)
Table Middle East Celiac Disease Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Celiac Disease Sales Volume Market Share by Countries in 2016
Table Middle East Celiac Disease Revenue (Million USD) by Countries (2012-2017)
Table Middle East Celiac Disease Revenue Market Share by Countries (2012-2017)
Figure Middle East Celiac Disease Revenue Market Share by Countries (2012-2017)
Figure Middle East Celiac Disease Revenue Market Share by Countries in 2016
Figure Saudi Arabia Celiac Disease Sales (K Units) and Growth Rate (2012-2017)
Figure Israel Celiac Disease Sales (K Units) and Growth Rate (2012-2017)
Figure UAE Celiac Disease Sales (K Units) and Growth Rate (2012-2017)
Figure Iran Celiac Disease Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Celiac Disease Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Celiac Disease Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Celiac Disease Sales (K Units) by Type (2012-2017)
Table Africa Celiac Disease Sales Market Share by Type (2012-2017)
Figure Africa Celiac Disease Sales Market Share by Type (2012-2017)
Figure Africa Celiac Disease Sales Market Share by Type in 2016
Table Africa Celiac Disease Sales (K Units) by Application (2012-2017)
Table Africa Celiac Disease Sales Market Share by Application (2012-2017)
Figure Africa Celiac Disease Sales Market Share by Application (2012-2017)
Table Africa Celiac Disease Sales Volume (K Units) by Countries (2012-2017)
Table Africa Celiac Disease Sales Market Share by Countries (2012-2017)
Figure Africa Celiac Disease Sales Market Share by Countries (2012-2017)
Figure Africa Celiac Disease Sales Market Share by Countries in 2016
Table Africa Celiac Disease Revenue (Million USD) by Countries (2012-2017)
Table Africa Celiac Disease Revenue Market Share by Countries (2012-2017)
Figure Africa Celiac Disease Revenue Market Share by Countries (2012-2017)
Figure Africa Celiac Disease Revenue Market Share by Countries in 2016
Figure South Africa Celiac Disease Sales (K Units) and Growth Rate (2012-2017)
Figure Nigeria Celiac Disease Sales (K Units) and Growth Rate (2012-2017)
Figure Egypt Celiac Disease Sales (K Units) and Growth Rate (2012-2017)
Figure Algeria Celiac Disease Sales (K Units) and Growth Rate (2012-2017)
Table F. Hoffmann-La Roche Celiac Disease Basic Information List
Table F. Hoffmann-La Roche Celiac Disease Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure F. Hoffmann-La Roche Celiac Disease Sales (K Units) and Growth Rate (2012-2017)
Figure F. Hoffmann-La Roche Celiac Disease Sales Market Share in EMEA (2012-2017)
Figure F. Hoffmann-La Roche Celiac Disease Revenue Market Share in EMEA (2012-2017)
Table Johnson & Johnson Celiac Disease Basic Information List
Table Johnson & Johnson Celiac Disease Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Johnson & Johnson Celiac Disease Sales (K Units) and Growth Rate (2012-2017)
Figure Johnson & Johnson Celiac Disease Sales Market Share in EMEA (2012-2017)
Figure Johnson & Johnson Celiac Disease Revenue Market Share in EMEA (2012-2017)
Table Merck Celiac Disease Basic Information List
Table Merck Celiac Disease Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Merck Celiac Disease Sales (K Units) and Growth Rate (2012-2017)
Figure Merck Celiac Disease Sales Market Share in EMEA (2012-2017)
Figure Merck Celiac Disease Revenue Market Share in EMEA (2012-2017)
Table Pfizer Celiac Disease Basic Information List
Table Pfizer Celiac Disease Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Pfizer Celiac Disease Sales (K Units) and Growth Rate (2012-2017)
Figure Pfizer Celiac Disease Sales Market Share in EMEA (2012-2017)
Figure Pfizer Celiac Disease Revenue Market Share in EMEA (2012-2017)
Table ADMA Biologics Celiac Disease Basic Information List
Table ADMA Biologics Celiac Disease Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure ADMA Biologics Celiac Disease Sales (K Units) and Growth Rate (2012-2017)
Figure ADMA Biologics Celiac Disease Sales Market Share in EMEA (2012-2017)
Figure ADMA Biologics Celiac Disease Revenue Market Share in EMEA (2012-2017)
Table Amgen Celiac Disease Basic Information List
Table Amgen Celiac Disease Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Amgen Celiac Disease Sales (K Units) and Growth Rate (2012-2017)
Figure Amgen Celiac Disease Sales Market Share in EMEA (2012-2017)
Figure Amgen Celiac Disease Revenue Market Share in EMEA (2012-2017)
Table Anthera Pharmaceuticals Celiac Disease Basic Information List
Table Anthera Pharmaceuticals Celiac Disease Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Anthera Pharmaceuticals Celiac Disease Sales (K Units) and Growth Rate (2012-2017)
Figure Anthera Pharmaceuticals Celiac Disease Sales Market Share in EMEA (2012-2017)
Figure Anthera Pharmaceuticals Celiac Disease Revenue Market Share in EMEA (2012-2017)
Table Bayer Celiac Disease Basic Information List
Table Bayer Celiac Disease Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Bayer Celiac Disease Sales (K Units) and Growth Rate (2012-2017)
Figure Bayer Celiac Disease Sales Market Share in EMEA (2012-2017)
Figure Bayer Celiac Disease Revenue Market Share in EMEA (2012-2017)
Table Biogen Celiac Disease Basic Information List
Table Biogen Celiac Disease Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Biogen Celiac Disease Sales (K Units) and Growth Rate (2012-2017)
Figure Biogen Celiac Disease Sales Market Share in EMEA (2012-2017)
Figure Biogen Celiac Disease Revenue Market Share in EMEA (2012-2017)
Table BioLineRx Celiac Disease Basic Information List
Table BioLineRx Celiac Disease Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure BioLineRx Celiac Disease Sales (K Units) and Growth Rate (2012-2017)
Figure BioLineRx Celiac Disease Sales Market Share in EMEA (2012-2017)
Figure BioLineRx Celiac Disease Revenue Market Share in EMEA (2012-2017)
Table Biotest Celiac Disease Basic Information List
Table Bristol-Myers Squibb Celiac Disease Basic Information List
Table Celgene Celiac Disease Basic Information List
Table Takeda Pharmaceutical Celiac Disease Basic Information List
Table Novartis Celiac Disease Basic Information List
Table LFB Group Celiac Disease Basic Information List
Table Kedrion Biopharma Celiac Disease Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Celiac Disease
Figure Manufacturing Process Analysis of Celiac Disease
Figure Celiac Disease Industrial Chain Analysis
Table Raw Materials Sources of Celiac Disease Major Manufacturers in 2016
Table Major Buyers of Celiac Disease
Table Distributors/Traders List
Figure EMEA Celiac Disease Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure EMEA Celiac Disease Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Celiac Disease Price (USD/Unit) and Trend Forecast (2017-2022)
Table EMEA Celiac Disease Sales (K Units) Forecast by Region (2017-2022)
Figure EMEA Celiac Disease Sales Market Share Forecast by Region (2017-2022)
Table EMEA Celiac Disease Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Celiac Disease Revenue Market Share Forecast by Region (2017-2022)
Table Europe Celiac Disease Sales (K Units) Forecast by Countries (2017-2022)
Figure Europe Celiac Disease Sales Market Share Forecast by Countries (2017-2022)
Table Europe Celiac Disease Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Celiac Disease Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Celiac Disease Sales (K Units) Forecast by Countries (2017-2022)
Figure Middle East Celiac Disease Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Celiac Disease Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Celiac Disease Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Celiac Disease Sales (K Units) Forecast by Countries (2017-2022)
Figure Africa Celiac Disease Sales Market Share Forecast by Countries (2017-2022)
Table Africa Celiac Disease Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Celiac Disease Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Celiac Disease Sales (K Units) Forecast by Type (2017-2022)
Figure EMEA Celiac Disease Sales Market Share Forecast by Type (2017-2022)
Table EMEA Celiac Disease Sales (K Units) Forecast by Application (2017-2022)
Figure EMEA Celiac Disease Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *